These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22520912)

  • 41. Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation study.
    Hippisley-Cox J; Coupland C; Vinogradova Y; Robson J; Brindle P
    Heart; 2008 Jan; 94(1):34-9. PubMed ID: 17916661
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identifying women with undetected ovarian cancer: independent and external validation of QCancer(®) (Ovarian) prediction model.
    Collins GS; Altman DG
    Eur J Cancer Care (Engl); 2013 Jul; 22(4):423-9. PubMed ID: 23121234
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development and Validation of a Prognostic Survival Model With Patient-Reported Outcomes for Patients With Cancer.
    Seow H; Tanuseputro P; Barbera L; Earle C; Guthrie D; Isenberg S; Juergens R; Myers J; Brouwers M; Sutradhar R
    JAMA Netw Open; 2020 Apr; 3(4):e201768. PubMed ID: 32236529
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation study.
    Pylypchuk R; Wells S; Kerr A; Poppe K; Riddell T; Harwood M; Exeter D; Mehta S; Grey C; Wu BP; Metcalf P; Warren J; Harrison J; Marshall R; Jackson R
    Lancet; 2018 May; 391(10133):1897-1907. PubMed ID: 29735391
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predicting dementia risk in primary care: development and validation of the Dementia Risk Score using routinely collected data.
    Walters K; Hardoon S; Petersen I; Iliffe S; Omar RZ; Nazareth I; Rait G
    BMC Med; 2016 Jan; 14():6. PubMed ID: 26797096
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predicting the risk of pancreatic cancer in adults with new-onset diabetes: development and internal-external validation of a clinical risk prediction model.
    Clift AK; Tan PS; Patone M; Liao W; Coupland C; Bashford-Rogers R; Sivakumar S; Hippisley-Cox J
    Br J Cancer; 2024 Jun; 130(12):1969-1978. PubMed ID: 38702436
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development and external validation of a COVID-19 mortality risk prediction algorithm: a multicentre retrospective cohort study.
    Mei J; Hu W; Chen Q; Li C; Chen Z; Fan Y; Tian S; Zhang Z; Li B; Ye Q; Yue J; Wang QL
    BMJ Open; 2020 Dec; 10(12):e044028. PubMed ID: 33361083
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical features of kidney cancer in primary care: a case-control study using primary care records.
    Shephard E; Neal R; Rose P; Walter F; Hamilton WT
    Br J Gen Pract; 2013 Apr; 63(609):e250-5. PubMed ID: 23540481
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk of urinary tract cancers following kidney or ureter stones.
    Chow WH; Lindblad P; Gridley G; Nyrén O; McLaughlin JK; Linet MS; Pennello GA; Adami HO; Fraumeni JF
    J Natl Cancer Inst; 1997 Oct; 89(19):1453-7. PubMed ID: 9326915
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Machine Learning and External Validation of the IDENTIFY Risk Calculator for Patients with Haematuria Referred to Secondary Care for Suspected Urinary Tract Cancer.
    Khadhouri S; Hramyka A; Gallagher K; Light A; Ippoliti S; Edison M; Alexander C; Kulkarni M; Zimmermann E; Nathan A; Orecchia L; Banthia R; Piazza P; Mak D; Pyrgidis N; Narayan P; Abad Lopez P; Nawaz F; Tran TT; Claps F; Hogan D; Gomez Rivas J; Alonso S; Chibuzo I; Gutierrez Hidalgo B; Whitburn J; Teoh J; Marcq G; Szostek A; Bondad J; Sountoulides P; Kelsey T; Kasivisvanathan V;
    Eur Urol Focus; 2024 Jun; ():. PubMed ID: 38906722
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Accuracy of ultrasound vs computed tomography scan for upper urinary tract malignancies and development of a risk-based diagnostic algorithm for haematuria in a UK tertiary centre.
    David RA; James B; Adeloye D; Bose P; Rai B; KandaSwamy GV
    Int Urol Nephrol; 2021 Jan; 53(1):49-57. PubMed ID: 32844354
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Derivation and external validation of risk algorithms for cerebrovascular (re)hospitalisation in patients with type 2 diabetes: Two cohorts study.
    Yu D; Cai Y; Graffy J; Holman D; Zhao Z; Simmons D
    Diabetes Res Clin Pract; 2018 Oct; 144():74-81. PubMed ID: 30114459
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development and validation of a cancer cachexia risk score for digestive tract cancer patients before abdominal surgery.
    Tan S; Xu J; Wang J; Zhang Z; Li S; Yan M; Tang M; Liu H; Zhuang Q; Xi Q; Meng Q; Jiang Y; Wu G
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):891-902. PubMed ID: 36880286
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnostic tests and algorithms used in the investigation of haematuria: systematic reviews and economic evaluation.
    Rodgers M; Nixon J; Hempel S; Aho T; Kelly J; Neal D; Duffy S; Ritchie G; Kleijnen J; Westwood M
    Health Technol Assess; 2006 Jun; 10(18):iii-iv, xi-259. PubMed ID: 16729917
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identifying patients with undetected gastro-oesophageal cancer in primary care: External validation of QCancer® (Gastro-Oesophageal).
    Collins GS; Altman DG
    Eur J Cancer; 2013 Mar; 49(5):1040-8. PubMed ID: 23159533
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development and Validation of the Chronic Disease Population Risk Tool (CDPoRT) to Predict Incidence of Adult Chronic Disease.
    Ng R; Sutradhar R; Kornas K; Wodchis WP; Sarkar J; Fransoo R; Rosella LC
    JAMA Netw Open; 2020 Jun; 3(6):e204669. PubMed ID: 32496565
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic models for identifying risk of poor outcome in people with acute ankle sprains: the SPRAINED development and external validation study.
    Keene DJ; Schlüssel MM; Thompson J; Hagan DA; Williams MA; Byrne C; Goodacre S; Cooke M; Gwilym S; Hormbrey P; Bostock J; Haywood K; Wilson D; Collins GS; Lamb SE
    Health Technol Assess; 2018 Nov; 22(64):1-112. PubMed ID: 30474592
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of Risk Prediction Equations for Incident Chronic Kidney Disease.
    Nelson RG; Grams ME; Ballew SH; Sang Y; Azizi F; Chadban SJ; Chaker L; Dunning SC; Fox C; Hirakawa Y; Iseki K; Ix J; Jafar TH; Köttgen A; Naimark DMJ; Ohkubo T; Prescott GJ; Rebholz CM; Sabanayagam C; Sairenchi T; Schöttker B; Shibagaki Y; Tonelli M; Zhang L; Gansevoort RT; Matsushita K; Woodward M; Coresh J; Shalev V;
    JAMA; 2019 Dec; 322(21):2104-2114. PubMed ID: 31703124
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Better survival of renal cell carcinoma in patients with inflammatory bowel disease.
    Derikx LA; Nissen LH; Drenth JP; van Herpen CM; Kievit W; Verhoeven RH; Mulders PF; Hulsbergen-van de Kaa CA; Boers-Sonderen MJ; van den Heuvel TR; Pierik M; Nagtegaal ID; Hoentjen F; ; ;
    Oncotarget; 2015 Nov; 6(35):38336-47. PubMed ID: 26447542
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Performance of prediction models for nephropathy in people with type 2 diabetes: systematic review and external validation study.
    Slieker RC; van der Heijden AAWA; Siddiqui MK; Langendoen-Gort M; Nijpels G; Herings R; Feenstra TL; Moons KGM; Bell S; Elders PJ; 't Hart LM; Beulens JWJ
    BMJ; 2021 Sep; 374():n2134. PubMed ID: 34583929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.